Advertisement

Advertisement

Op-Ed

Advertisement

Advertisement



Sep
22
Today In Oncology
Ivosidenib/Azacitidine for Newly Diagnosed AML
Two Studies Show Variation in Effectiveness of Mammography Across Populations
End-of-Life Care in Western Washington State vs Alberta, Canada
Individualized Axitinib Regimens After Immunotherapy for RCC
Improving Documentation of Pain and Constipation Assessment and Management
View More 
Advertisement
Most Read Stories
Patients With Metastatic Colorectal Cancer Carrying Class 3 BRAF Mutations May Respond to Anti-EGFR Therapy
ASTRO 2019: Patterns of Disease Progression in Patients With Unresectable Stage III NSCLC: Analysis of the PACIFIC Trial
FDA Approves Apalutamide for Metastatic Castration-Sensitive Prostate Cancer
International Guidelines for Treatment and Prophylaxis of VTE in Patients With Cancer
Meta-analysis of Chemotherapy and Hormonal Treatments for Postmenopausal Women With Metastatic Breast Cancer
View More 
Most Viewed Videos
Angela M. Stover, PhD, on Patient-Reported Outcome Performance Measures for Oncology Practice
Lauren M. Hamel, PhD, on Race and Doctor-Patient Behavior
Nadine Housri, MD, on Online Tumor Boards: A New Resource for Practicing Oncologists
Brian I. Rini, MD, on Renal Cell Carcinoma: Results From the TIVO-3 Trial on Tivozanib vs Sorafenib
Matthew B. Schabath, PhD, on Addressing Cultural Barriers to Equality in Oncology Among Sexual and Gender Minorities
View More 
© 2019 HSP News Service, L.L.C.